MY
Noveris Health Sciences Inc.
MYCOF · OTC
$0.73 +0.00% (+$0.00)
Market Cap $65.5M
P/E Ratio 40.11x
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
2 /100
Expensive EV/EBITDA 30.28x
P/E 40.11x
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
79 /100
Excellent ROA 165.32%
Asset turnover 0.00x
ROIC 49.67%
Debt
79 /100
Low Int. coverage 46.96x
Net debt/EBITDA -0.20x
Current ratio 0.31x
Stability
50 /100
Moderate Beta -5.44x
EPS volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MYCOF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Jason Birmingham
Employees
3
Headquarters
Vancouver
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report